Back | Next |
home / stock / gnpx / gnpx message board
Subject | By | Source | When |
---|---|---|---|
Looking like another low volume manipulation pump day. | trendzone | investorshub | 01/12/2022 5:56:56 PM |
Looking good | europtiger | investorshub | 01/11/2022 6:36:12 PM |
2,28 back in | europtiger | investorshub | 01/11/2022 5:32:32 PM |
Pls go all the way back in my | europtiger | investorshub | 01/11/2022 5:31:43 PM |
whytestocks: $GNPX News Article - InvestorNewsBreaks - Genprex Inc. (NASDAQ: GNPX) to Accelerate Ope | whytestocks | investorshangout | 01/10/2022 6:15:48 PM |
With still being over bought, it could be | trendzone | investorshub | 01/06/2022 3:14:54 PM |
Dark Red | howardriggin | investorshub | 01/05/2022 3:49:42 PM |
Fake Investors of $GNPX, since the DD has | laraz5 | investorshub | 01/05/2022 2:25:39 PM |
Who wants to bet if today a green | J2003 | investorshub | 01/05/2022 1:12:08 PM |
Tomorrow sounds like round 2 for a run | J2003 | investorshub | 01/04/2022 8:48:46 PM |
Man, you sound angry | maximumgriff | investorshub | 01/04/2022 8:14:17 PM |
Tomorrow we may have another runwait to see | J2003 | investorshub | 01/04/2022 6:03:10 PM |
Complete Bullshit! You were not? $IMO | laraz5 | investorshub | 01/04/2022 5:14:40 PM |
Not in I was in the run a | europtiger | investorshub | 01/04/2022 4:37:53 PM |
Yeah better wait for opening bell | europtiger | investorshub | 01/04/2022 1:25:38 PM |
I rode this yesterday after-hours to $4.00 | Pedro2004 | investorshub | 01/04/2022 1:24:59 PM |
I just follow directors from bankruptcy to bankruptcy | laraz5 | investorshub | 01/04/2022 1:16:19 PM |
I hope not but it did look a | europtiger | investorshub | 01/04/2022 1:13:16 PM |
I was trying to figure-out where the shares | Pedro2004 | investorshub | 01/04/2022 1:11:50 PM |
Why you spend so much time ragging this | maximumgriff | investorshub | 01/04/2022 1:10:36 PM |
News, Short Squeeze, Breakout and More Instantly...
Genprex Issues Stockholder Letter and Provides 2024 Corporate Update PR Newswire Company Achieves Multiple Clinical Development Milestones in 2024 Patient Treatment Continues in Three Lung Cancer Clinical Trials AUSTIN, Texas , June 27, 2024 /PRNe...
Genprex to Present at the 2024 BIO International Convention PR Newswire Presentation to Highlight the Company's Gene Therapies for Cancer and Diabetes AUSTIN, Texas , May 30, 2024 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: ...